Xenon Pharmaceuticals XENE
NASDAQ XENE
$37.47 -1.46 (-3.74%)
As of: Oct 2, 2026 · 1:06 PM EDT

Xenon Pharmaceuticals (XENE) Non-Current Deffered Revenue (2013 - 2019)

Updated

Xenon Pharmaceuticals' Non-Current Deffered Revenue came in at $709,000 for Q4 2019.

Analysis

Xenon Pharmaceuticals (XENE) Non-Current Deffered Revenue (2013 - 2019) Analysis & Trends

Going back to Q4 2013, Xenon Pharmaceuticals' Non-Current Deffered Revenue data covers 4 quarters.

  • Non-Current Deffered Revenue carries a five-year compound annual growth rate of 35.2% (FY2014 to FY2019).
  • The Q4 2019 figure represents the highest quarterly Non-Current Deffered Revenue since Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Xenon Pharmaceuticals 3.60 Bn 3.60 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 709,000.00
Dec 31, 2014 157,000.00
Sep 30, 2014 2.60 Mn
Dec 31, 2013 11.89 Mn
API Access

Xenon Pharmaceuticals Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=XENE&period=max&api_key=YOUR_API_KEY